Physician profile
Andrew Lee
NPI 1295053700
$1,407.27
in general payments reported to CMS, 2019-2025
12 companies · $46.95 in 2025
The $46.95 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $15.00 · 2021: $112 · 2022: $21.75 · 2023: $91.01 · 2024: $910 · 2025: $46.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.14 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rivanna Medical, INC | $300.00 | 2024 | Accuro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.48 | 2019-2024 | Jardiance |
| Tris Pharma INC | $207.75 | 2022-2025 | Dyanavel Xr |
| Janssen Pharmaceuticals, INC | $149.16 | 2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $118.13 | 2024 | Cobenfy |
| Bayer Healthcare Pharmaceuticals INC. | $111.92 | 2024 | |
| Bard Peripheral Vascular, INC. | $100.00 | 2019 | |
| Abbott Laboratories | $61.30 | 2021 | |
| Novo Nordisk INC | $33.59 | 2020-2021 | |
| Biomerieux INC | $32.00 | 2021 | |
| Inspire Medical Systems, INC. | $29.88 | 2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $28.06 | 2024 | Eohilia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.